Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (105 ops.)
Latest filing published 19 Mar 2020 for Biodelivery Sciences International INC, €28k.
Filing timeline
BuySaleBroadfin Healthcare Master Fund Ltd
Insider track record
Disclosed buys
6
Disclosed sells
105
Signal history
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Broadfin Healthcare Master Fund Ltd: trading record in brief
Broadfin Healthcare Master Fund Ltd discloses dealings in 10 companies, chiefly Societal CDMO, Inc., Aratana Therapeutics, Inc. and Progenics Pharmaceuticals Inc. The record holds 122 filings, for trades running from 10 March 2016 to 17 March 2020.
Market trades split into 6 purchases (€6.8M) and 105 sales (€83.1M). The net balance comes to €76.3M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants and 1 option exercise.
In size, the median ticket on the buying side is €146k.
Most recently, on 19 March 2020, the filings show an option exercise worth €28k in Biodelivery Sciences International Inc. The clock since the last published purchase (14 December 2016) now reads 3,600 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Broadfin Healthcare Master Fund Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations121 total
10,623 shares@ US$2.930.1% of flowCommon StockSEC:0000919574-20-002503:0
250,000 shares@ US$6.442.4% of flowCommon StockSEC:0000919574-19-007768:0
750,000 shares@ US$6.507.3% of flowCommon StockSEC:0000919574-19-007768:1
1,000,000 shares@ US$6.329.5% of flowCommon StockSEC:0000919574-19-007768:2
2,000,000 shares@ US$1.805.4% of flowCommon StockSEC:0000919574-19-007768:3
2,206,243 shares@ US$6.03720.2% of flowCommon StockSEC:0000919574-19-007363:0
293,757 shares@ US$5.90342.6% of flowCommon StockSEC:0000919574-19-007363:1
1,500,000 shares@ US$5.9013.4% of flowCommon StockSEC:0000919574-19-007363:2
4,000,000 shares@ US$1.8010.9% of flowCommon StockSEC:0000919574-19-007363:3
7,258,135 sharesCommon StockSEC:0000919574-19-004716:0
1,800,000 shares@ US$5.0013.4% of flowCommon StockSEC:0000919574-19-003369:0
2,000,000 shares@ US$5.0014.8% of flowCommon StockSEC:0000919574-19-002943:0
400 shares@ US$0.980.1% of flowCommon Shares, without par valueSEC:0000919574-18-008175:0
1,200 shares@ US$0.93250.3% of flowCommon Shares, without par valueSEC:0000919574-18-008175:1
83,245 shares@ US$0.978420.3% of flowCommon Shares, without par valueSEC:0000919574-18-008175:2
12,450 shares@ US$0.90782.8% of flowCommon Shares, without par valueSEC:0000919574-18-008175:3
109,900 shares@ US$0.87223.8% of flowCommon Shares, without par valueSEC:0000919574-18-008175:4
12,219 shares@ US$0.90912.8% of flowCommon Shares, without par valueSEC:0000919574-18-008175:5
28,745 shares@ US$0.90586.5% of flowCommon Shares, without par valueSEC:0000919574-18-008175:6
30,726 shares@ US$0.9076.9% of flowCommon Shares, without par valueSEC:0000919574-18-008175:7
14,800 shares@ US$0.88033.3% of flowCommon Shares, without par valueSEC:0000919574-18-008175:8
56,316 shares@ US$0.854812.0% of flowCommon Shares, without par valueSEC:0000919574-18-008175:9
100,000 shares@ US$0.851421.3% of flowCommon Shares, without par valueSEC:0000919574-18-008175:10
4,474,995 sharesCommon StockSEC:0000919574-18-007778:0
29,300 shares@ US$5.84Common Stock, $0.01 par value per shareSEC:0000919574-18-003940:0
25 of 121 declarations
